定义COPD的非eosinophilic炎症亚型:CXCL9和1型免疫反应的作用
Yin Chengsheng1, Song Jiacui1, Takehiro Hasegawa2
1Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Frontiers in immunology
|May 2, 2025
概括
在患有慢性阻塞性肺病 (COPD) 和间歇性肺病 (ILD) 的患者中,C-X-C动机化学因子配体9 (CXCL9) 血清水平升高. 较高的CXCL9水平与COPD的疾病严重性标志物相关,这表明它在呼吸道炎症中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 生物化学 生物化学
背景情况:
- C-X-C 基因化学因子接体9 (CXCL9) 是干扰素γ诱导的,是T-辅助1 (Th1) 细胞的标记物.
- 在间歇性肺病 (ILD),COVID-19和喘中,CXCL9的表达升高.
- 在慢性阻塞性肺病 (COPD) 病理生理学中,Th1化学基因的作用尚未完全理解.
研究的目的:
- 为了研究C-X-C动机化学因子连接体9 (CXCL9) 和慢性呼吸道疾病之间的关系.
- 评估COPD和ILD患者的血清CXCL9水平.
主要方法:
- 对165名患有ILD和COPD的患者进行了回顾性队列研究.
- 分析了CXCL9,表面活性蛋白A (SP-A),Krebs von den Lungen-6 (KL-6) 和C反应蛋白 (CRP) 的血清水平.
- 进行了无监督的等级集群分析来进行数据集群.
主要成果:
- 与健康对照组相比,COPD和ILD患者的血清CXCL9水平显著更高.
- 慢性肺炎患者的CXCL9水平与KL-6,SP-A,血中乙氨基酸比率,乳酸脱酶 (LDH) 和CRP相关.
- 在非乙性慢性肺炎患者中,高CXCL9水平与增加的LDH,KL-6和中性粒细胞比率有关.
结论:
- CXCL9可能在COPD的炎症过程中发挥重要作用.
- 较高的CXCL9水平与COPD中的特定生物标志物和疾病特征有关.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Asthma: Pathogenesis and Management
225
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
225
COPD: Pathogenesis and Clinical Features
170
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
170
COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117


